| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |